Address
Sofinnova Ventures Inc
2800 Sand Hill Road
Suite 150
Menlo Park, CA 94025
United States
Phone
Website
Recent investment activity
KANDO id: 2247
Funds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR |
|---|---|---|---|---|---|
| Sofinnova Industrial Biotech | Venture | 2017 | EUR | 106,000,000 | |
| Sofinnova Venture Partners X LP | Venture | 2016 | USD | 650,000,000 | |
| Sofinnova Venture Partners IX LP | Venture | 2014 | USD | 500,000,000 | |
| Sofinnova Venture Partners VIII LP | Venture | 2011 | USD | 440,000,000 | |
| Sofinnova Venture Partners VII LP | Venture | 2006 | USD | 375,000,000 | 17.11 % |
| Sofinnova Venture Partners VI | Venture | 2003 | USD | 220,000,000 | -6.03 % |
| Sofinnova Venture Partners V | Venture | 2000 | USD | 210,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 48| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Ascenta Therapeutics Inc | A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. | N/A | |||
|
|
Auris Medical | Series C | ||||
|
BeamReach Networks Inc | N/A | ||||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | |||
|
|
Cebix Inc | Series B | ||||
|
|
Cebix Inc | N/A | ||||
|
|
Cellective Therapeutics Inc | N/A | ||||
|
|
CoAxia Inc | A medical device company that researches therapy and treatment solutions for cerebral ischemia | Series D | |||
|
|
Contextream Inc | ConteXtream is a privately held software company. | Series A | |||
|
|
Cortina Systems Inc | N/A | ||||
|
|
CoTherix Inc | N/A | ||||
|
|
DiObex Inc | Biotechnology company that develops novel products for the treatment of metabolic disorders. | N/A | |||
|
|
Durata Therapeutics Inc | Durata Therapeutics is a clinical development stage biopharmaceutical company. | N/A | |||
|
|
Envivio Inc | Developer of MPEG-4 solutions for broadcasters, enterprises, and service providers. | N/A | |||
|
|
Flexion Therapeutics Inc | Discovers and develops innovative therapeutics for musculoskeletal disorders | N/A | |||
|
|
Histogenics Corp | Histogenics Corporation expertise and focus is on repairing articular cartilage damage. | Series A | |||
|
|
Hyperion Therapeutics Inc | Hyperion Therapeutics is a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs i | N/A | |||
|
|
INSIDE Secure SA | N/A | ||||
|
|
InterMune Inc | N/A | ||||
|
|
KaloBios Pharmaceuticals Inc | Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity | N/A | |||
|
|
Kosan Biosciences Inc | N/A | ||||
|
|
Laszlo Systems Inc | N/A | ||||
|
|
Marinus Pharmaceuticals Inc | Development of therapeutics for treatment of CNS disorders and pain | Series B |
Team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Eric Buatois | Benhamou Global Ventures LLC |